FR

Eyegate Pharma S.a.s.

USPTO Granted Patents = 11

% Expired Patents = 100.0



Forward Citations = 115

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Pierre Roy (11 out of 53 patents)

silverMedal Francine Behar-Cohen (2 out of 21 patents)

bronzeMedal Francine Behar (1 out of 2 patents)

4.  Alain Kleinsinger (1 out of 1 patent)


11 patents:

Company Overview
Eyegate Pharma S.a.s. is a biopharmaceutical company based in France, specializing in the development of innovative therapies for ocular diseases. The organization focuses on advanced drug delivery systems, particularly for the treatment of conditions affecting the eye. With a commitment to enhancing patient care, Eyegate Pharma leverages its proprietary technologies to create effective solutions that address unmet medical needs in ophthalmology. The company is dedicated to research and development, aiming to improve the quality of life for patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#79 in

#1,584 in France

#51,801 in the World

FR
FR
Forward Citations = 115

4 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eyegate Pharma S.a.s.. Retrieved from https://idiyas.com/company/eyegate-pharma-s-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…